
    
      Subjects previously primed with Tritanrix-HepB/Hib-MenAC will receive
      Tritanrix-HepB/Hib-MenAC or Tritanrix-HepB/Hiberix vaccine (at 15-18/24 m), respectively,
      without or with Mencevax ACWY vaccine at 24 to 30 months of age. Subjects previously primed
      with Tritanrix-HepB/Hiberix will receive Tritanrix-HepB/Hib-MenAC or Tritanrix-HepB/Hiberix
      vaccine (at 15-18/24 m) with Mencevax ACWY vaccine at 24 to 30 months of age.
    
  